Working with mice and human patients, Eric Pamer, Carles Ubdea, and colleagues, at Memorial Sloan-Kettering Cancer Center, New York, have generated data that suggest that high-throughput DNA sequencing of bacteria in the…
Tag: virus
Humanitarian benefits of rapid cholera vaccines deployment to at risk areas could be enormous
Vaccine delivery to as-yet-unaffected parts of Haiti could help stabilize the country’. In the wake of devastating cholera outbreaks in refugee camps in earthquake-wracked Haiti, a group of leading experts from Harvard…
Specialists suggest United States should stockpile cholera vaccines for rapid deployment at disease outbreak
As the cholera epidemic in Haiti continues to rage, public health workers are focusing their efforts on treating the tens of thousands who have already been hospitalized with cholera-like symptoms and providing…
E. coli host bacterium produces antibiotic erythromycin A
Biosynthetic breakthrough paves way for other pharmaceuticals. Researchers at Tufts University School of Engineering have reported the first successful production of the antibiotic erythromycin A, and two variations, using E. coli as…
FTC/TDF tablet reduces HIV infection among high-risk individuals
Major study published in the New England Journal of Medicine demonstrates the effectiveness of a new HIV prevention tool, pre-exposure prophylaxis (PrEP). In a finding with the potential to fundamentally change strategies…
SIRS-Lab, Pfizer collaborate to improve patients’ outcome with sepsis
SIRS-Lab GmbH, a molecular diagnostics company based in Jena, Germany, and Pfizer Pharma GmbH, headquartered in Berlin, have announced a collaboration in the field of sepsis. The aim of this collaboration is…
CIHI study finds impact of H1N1 pandemic on Canadian hospitals
While the H1N1 global pandemic may not have resulted in as many severe cases as originally predicted, a new study released today by the Canadian Institute for Health Information (CIHI) shows that…
Daily oral antiretroviral reduces HIV infection risk in MSM by 44%, study finds
A study that included nearly 2,500 HIV-negative men and transgender women who have sex with men has shown that a daily dose of Truvada, a pill containing the AIDS drugs emtricitabine and…
Study estimates cost savings associated with global polio eradication; global post examines vaccination efforts in Africa
Research published in the November issue of the journal Vaccine found that a global campaign to eliminate polio could save between $40 billion and $50 billion “over the next few decades if…
Meningitis immunization program to launch in 3 African countries next month
At a press conference in London, health officials said that the anticipated roll-out of the MenAfriVac for meningitis in three African countries will start on Dec. 6, the BBC reports. “The vaccine,…
Preclinical trial shows Chimerix’s CMX001 inhibits HSV replication
Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, today announced that data demonstrating preclinical efficacy of Chimerix’s lead antiviral compound CMX001 against herpes simplex virus (HSV) as well as its ability…
WHO Calls On Malaria-Endemic Countries To Strengthen Monitoring Of Antimalarial Drug Efficacy
WHO is calling on countries to be increasingly vigilant in monitoring antimalarial drug efficacy in order to allow for early detection of artemisinin resistance.1 This is one among several conclusions of the…
Scientists Discover That Bacteria Use ‘Toxic Darts’ To Disable Each Other
In nature, it’s a dog-eat-dog world, even in the realm of bacteria. Competing bacteria use “toxic darts” to disable each other, according to a new study by UC Santa Barbara biologists. Their…
AHF hails Pope Benedict’s remarks on condom usage to prevent HIV transmission
AIDS Healthcare Foundation, the largest global AIDS organization, today hailed recent remarks by Pope Benedict XVI on the “justified” use condoms to prevent the spread of potentially deadly diseases like HIV that…
IVCC receives $50 million to develop new insecticides
The Innovative Vector Control Consortium (IVCC) has received $50 million from the Bill & Melinda Gates Foundation to continue its work to develop new insecticides for the improved control of mosquitoes and…